FDA reaches agreement with firm that produced troubled heart drug

The U.S. Food and Drug Administration last week announced a little-noticed tentative agreement setting conditions under which a troubled pha

Related to this story

Drug makers' dime funds Congressional travel

By Robert Brodsky

Deep pockets contribute to success

By M. Asif Ismail

Surrogates for their agenda

By Alexander Cohen

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

Excerpts from this story referencing "FDA’s Center for Drug Evaluation and Research":

"… FDA approval. Commenting on the agreement, Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said, “The FDA will not allow manufacturers to put the public’s healt …"

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

Before a new drug finds its place on pharmacy shelves or a new device lands in the hands of a surgeon, it goes through a long and complex ap

Related to this story

FDA: A shell of its former self

By M. Asif Ismail

Drug industry influence timeline

By The Center for Public Integrity

FDA staff travels on drug industry dollars

By Alexander Cohen

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Excerpts from this story referencing "FDA’s Center for Drug Evaluation and Research":

"… testing and animal studies before the drugmaker submits an application to FDA’s Center for Drug Evaluation and Research. If it gets the agency’s green light, then the human clinical trials beg …"

FDA enforcement actions way down

By The Center for Public Integrity

Enforcement actions by the (FDA) markedly declined under the Bush administration

Related to this story

FDA screening of fish imports not catching antibiotics and drug residue

By Laurel Adams

FDA lags USDA in accessible food safety data

By Jim Morris

Inspectors struggle to keep up with flood of imports

By Brad Racino

Amid digital records surge, a lack of policing by the FDA

By Emma Schwartz and Fred Schulte

Excerpts from this story referencing "FDA’s Center for Drug Evaluation and Research":

"… label abuses, limiting their effectiveness.Follow-up:A spokeswoman for the FDA’s Center for Drug Evaluation and Research told the Center that since companies have better complied after receiving …"

Advertisement

Lack of adequate foreign drug oversight

By The Center for Public Integrity

The GAO called for improvement in the FDA’s Foreign Drug Inspection Program in 1998. A decade later, there's been little improvement.

Related to this story

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

FDA: A shell of its former self

By M. Asif Ismail

FDA staff travels on drug industry dollars

By Alexander Cohen

Drug industry influence timeline

By The Center for Public Integrity

Excerpts from this story referencing "FDA’s Center for Drug Evaluation and Research":

"… tured at a Chinese facility, was contaminated. Janet Woodcock, director of FDA’s Center for Drug Evaluation and Research, told a House panel in early 2008 that her agency faced “an ever-growing …"

"… ened in China. In response to a request for comment, a spokeswoman for the FDA’s Center for Drug Evaluation and Research noted the agency’s comments in response to a September 2008 GAO report i …"